
Sign up to save your podcasts
Or
Send us a text
Canada-based PharmAla Biotech's Founding CEO and President Nick Kadysh joins WTR's Tim Regan and Robert Sassoon to discuss PharmAla's focus on MDMA, the regulatory environment, and the company's recipe for success in the psychedelics space. Founded three years ago, the company reported annualized revenue of C$3 million and achieved a first-time profit for its most recent reported quarter.
5
66 ratings
Send us a text
Canada-based PharmAla Biotech's Founding CEO and President Nick Kadysh joins WTR's Tim Regan and Robert Sassoon to discuss PharmAla's focus on MDMA, the regulatory environment, and the company's recipe for success in the psychedelics space. Founded three years ago, the company reported annualized revenue of C$3 million and achieved a first-time profit for its most recent reported quarter.
1,512 Listeners
3,189 Listeners
223,354 Listeners
1,000 Listeners
645 Listeners
3,368 Listeners
1,774 Listeners
3,068 Listeners
186 Listeners
206 Listeners
89 Listeners
5,231 Listeners
101 Listeners
245 Listeners
2,147 Listeners